Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lobefalo

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
International Journal of Immunopathology and Pharmacology|June 5, 2003
Dry eye in allergic conjunctivitis: role of inflammatory infiltrateL Lobefalo, E D'Antonio, L Colangelo, et al.
Journal of Biological Regulators and Homeostatic Agents|December 18, 2012
Can latent synergism of intestinal pathogens be responsible for inflammaging process causing Reiter's syndrome in a young patient HLA-B27 infected by atypical pathogens? A holistic view and clinical biochemical reinterpretationM Del Boccio, L Lobefalo, A Pennelli, et al.
International Journal of Immunopathology and Pharmacology|June 10, 2003
Allergen immunotherapy: an effective immune-modifierM Di Gioacchino, E Cavallucci, M B Di Sciascio, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1991
Patterns of cytomegalovirus retinitis in immunocompromised patients treated with 9-(2-hydroxy-1-(hydroxymethyl)ethoxymethyl) guanine (ganciclovir)D D'Antonio, A Iacone, G Fioritoni, et al.
Journal of Biological Regulators and Homeostatic Agents|March 6, 2018
Diagnosis of a neonatal ophthalmic discharge, Ophthalmia neonatorum, in the molecular age: investigation for a correct therapyP E Gallenga, M Del Boccio, C E Gallenga, et al.
Immunobiology|June 2, 2000
Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitisM Di Gioacchino, E Cavallucci, M B Di Sciascio, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|July 27, 1999
Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III studyP E Gallenga, L Lobefalo, L Colangelo, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
International Journal of Immunopathology and Pharmacology|June 5, 2003
Dry eye in allergic conjunctivitis: role of inflammatory infiltrateL Lobefalo, E D'Antonio, L Colangelo, et al.
Journal of Biological Regulators and Homeostatic Agents|December 18, 2012
Can latent synergism of intestinal pathogens be responsible for inflammaging process causing Reiter's syndrome in a young patient HLA-B27 infected by atypical pathogens? A holistic view and clinical biochemical reinterpretationM Del Boccio, L Lobefalo, A Pennelli, et al.
International Journal of Immunopathology and Pharmacology|June 10, 2003
Allergen immunotherapy: an effective immune-modifierM Di Gioacchino, E Cavallucci, M B Di Sciascio, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1991
Patterns of cytomegalovirus retinitis in immunocompromised patients treated with 9-(2-hydroxy-1-(hydroxymethyl)ethoxymethyl) guanine (ganciclovir)D D'Antonio, A Iacone, G Fioritoni, et al.
Journal of Biological Regulators and Homeostatic Agents|March 6, 2018
Diagnosis of a neonatal ophthalmic discharge, Ophthalmia neonatorum, in the molecular age: investigation for a correct therapyP E Gallenga, M Del Boccio, C E Gallenga, et al.
Immunobiology|June 2, 2000
Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitisM Di Gioacchino, E Cavallucci, M B Di Sciascio, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|July 27, 1999
Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III studyP E Gallenga, L Lobefalo, L Colangelo, et al.
Pageof 4